Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823730 · ClinicalTrials.gov registry record
Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 500
- Enrollment target
NCT02823730: Completed study, sponsored by Medstar Health Research Institute.
NCT02823730 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823730 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have received the Promus Premier drug-eluting stent with durable polymer.
Primary Outcome
major adverse cardiac events (MACE), defined as the composite of: 1. All-cause death; 2. Q-wave myocardial infarction (QwMI): appearance of new pathologic Q waves in the coronary distribution of the target vessel with an increase of creatine kinase-MB to ≥2 times the reference values (if available); 3. Target vessel revascularization (TVR): need for repeat PCI within the target vessel.
Interventions
- OTHER PCI with Synergy Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-07 |
| Est. Completion | 2023-05 |
What the finished NCT02823730 record still lists
NCT02823730 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which PCI with Synergy Stent is the first listed.
NCT02823730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823730 about?
NCT02823730 is a clinical study titled "Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy". To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have received the Promus Premier drug-eluting stent with durable polymer.
What is the current status of trial NCT02823730?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2016-07. Estimated completion is 2023-05.
What interventions are being tested in trial NCT02823730?
The interventions under investigation include: PCI with Synergy Stent (OTHER).
Who is sponsoring clinical trial NCT02823730?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia